• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDA5 调控肺上皮细胞中 SARS-CoV-2 的先天免疫反应。

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.

机构信息

Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, P.R. China.

Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

出版信息

Cell Rep. 2021 Jan 12;34(2):108628. doi: 10.1016/j.celrep.2020.108628.

DOI:10.1016/j.celrep.2020.108628
PMID:33440148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832566/
Abstract

Recent studies have profiled the innate immune signatures in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and suggest that cellular responses to viral challenge may affect disease severity. Yet the molecular events that underlie cellular recognition and response to SARS-CoV-2 infection remain to be elucidated. Here, we find that SARS-CoV-2 replication induces a delayed interferon (IFN) response in lung epithelial cells. By screening 16 putative sensors involved in sensing of RNA virus infection, we found that MDA5 and LGP2 primarily regulate IFN induction in response to SARS-CoV-2 infection. Further analyses revealed that viral intermediates specifically activate the IFN response through MDA5-mediated sensing. Additionally, we find that IRF3, IRF5, and NF-κB/p65 are the key transcription factors regulating the IFN response during SARS-CoV-2 infection. In summary, these findings provide critical insights into the molecular basis of the innate immune recognition and signaling response to SARS-CoV-2.

摘要

最近的研究描绘了感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的患者的固有免疫特征,并表明细胞对病毒挑战的反应可能影响疾病的严重程度。然而,细胞识别和对 SARS-CoV-2 感染的反应的分子事件仍有待阐明。在这里,我们发现 SARS-CoV-2 复制诱导肺上皮细胞中干扰素(IFN)反应的延迟。通过筛选 16 种参与 RNA 病毒感染检测的假定传感器,我们发现 MDA5 和 LGP2 主要调节 SARS-CoV-2 感染时 IFN 的诱导。进一步的分析表明,病毒中间体通过 MDA5 介导的感应特异性激活 IFN 反应。此外,我们发现 IRF3、IRF5 和 NF-κB/p65 是调节 SARS-CoV-2 感染期间 IFN 反应的关键转录因子。总之,这些发现为 SARS-CoV-2 的固有免疫识别和信号转导反应的分子基础提供了重要的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/ee26934e277c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/c41a9bb2116c/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/f34ddd3028b4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/563bf6603a8c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/d98e976c5a6c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/90d27dc766ac/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/ee26934e277c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/c41a9bb2116c/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/f34ddd3028b4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/563bf6603a8c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/d98e976c5a6c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/90d27dc766ac/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e164/7832566/ee26934e277c/gr5_lrg.jpg

相似文献

1
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.MDA5 调控肺上皮细胞中 SARS-CoV-2 的先天免疫反应。
Cell Rep. 2021 Jan 12;34(2):108628. doi: 10.1016/j.celrep.2020.108628.
2
RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.RIG-I 样受体介导的严重急性呼吸综合征冠状病毒 2 病毒基因组 RNA 的识别及病毒逃避宿主固有免疫反应。
Front Immunol. 2021 Jun 25;12:700926. doi: 10.3389/fimmu.2021.700926. eCollection 2021.
3
MDA5 and LGP2 acts as a key regulator though activating NF-κB and IRF3 in RLRs signaling of mandarinfish.MDA5 和 LGP2 通过激活 RLRs 信号通路中的 NF-κB 和 IRF3 发挥关键调节作用。
Fish Shellfish Immunol. 2019 Mar;86:1114-1122. doi: 10.1016/j.fsi.2018.12.054. Epub 2018 Dec 28.
4
Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication.LGP2 变异对 MDA5 介导的干扰素反应激活和抑制乙型肝炎病毒复制的影响。
J Hepatol. 2023 Jan;78(1):78-89. doi: 10.1016/j.jhep.2022.08.041. Epub 2022 Sep 22.
5
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.SARS-CoV-2 的 ORF9b 通过靶向 RIG-I/MDA-5-MAVS、TLR3-TRIF 和 cGAS-STING 信号通路的多个成分来拮抗 I 型和 III 型干扰素。
J Med Virol. 2021 Sep;93(9):5376-5389. doi: 10.1002/jmv.27050. Epub 2021 May 9.
6
SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.RIG-I 和 MDA5 对 SARS-CoV-2 的感应将上皮细胞感染与巨噬细胞炎症联系起来。
EMBO J. 2021 Aug 2;40(15):e107826. doi: 10.15252/embj.2021107826. Epub 2021 Jul 2.
7
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.SARS-CoV-2 诱导呼吸道上皮细胞和心肌细胞中双链 RNA 介导的先天免疫反应。
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2022643118.
8
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.SARS-CoV-2 分离株在人免疫细胞中的复制能力受损,但在肺上皮细胞中的复制能力和诱导先天免疫能力存在差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0077421. doi: 10.1128/Spectrum.00774-21. Epub 2021 Aug 11.
9
The RNA sensor MDA5 detects SARS-CoV-2 infection.RNA 传感器 MDA5 可检测 SARS-CoV-2 感染。
Sci Rep. 2021 Jul 1;11(1):13638. doi: 10.1038/s41598-021-92940-3.
10
Differential roles of RIG-I like receptors in SARS-CoV-2 infection.RIG-I 样受体在 SARS-CoV-2 感染中的差异作用。
Mil Med Res. 2021 Sep 7;8(1):49. doi: 10.1186/s40779-021-00340-5.

引用本文的文献

1
SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment.严重急性呼吸综合征冠状病毒2型肺炎:诊断与治疗进展
Microorganisms. 2025 Jul 31;13(8):1791. doi: 10.3390/microorganisms13081791.
2
A pilot transcriptomic study of a novel multitargeted BRT regimen for anti-MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy.一项针对抗MDA5抗体阳性皮肌炎的新型多靶点BRT方案的初步转录组学研究:与传统疗法相比提高生存率。
Front Immunol. 2025 Aug 7;16:1568338. doi: 10.3389/fimmu.2025.1568338. eCollection 2025.
3
Pattern recognition receptor-associated immuno-thrombotic transcript changes in platelets and leukocytes with COVID19.

本文引用的文献

1
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.新型冠状病毒2型疫苗接种——一盎司(实际上远少于此)的预防措施。
N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717. Epub 2020 Dec 10.
2
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.通过I/III型干扰素的时间模式及流感对比揭示的新冠病毒感染中失调的抗病毒免疫
Nat Immunol. 2021 Jan;22(1):32-40. doi: 10.1038/s41590-020-00840-x. Epub 2020 Dec 4.
3
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
新型冠状病毒肺炎患者血小板和白细胞中模式识别受体相关免疫血栓形成转录变化
PLoS Pathog. 2025 Aug 18;21(8):e1013413. doi: 10.1371/journal.ppat.1013413. eCollection 2025 Aug.
4
Catch me if you can: viral nucleic acids to host sensors.若你能,就抓住我:病毒核酸与宿主传感器。
Front Immunol. 2025 Jul 28;16:1632283. doi: 10.3389/fimmu.2025.1632283. eCollection 2025.
5
SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway.衰老内皮细胞中SARS-CoV-2的摄取和炎症反应受BSG/VEGFR2途径调控。
Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2502724122. doi: 10.1073/pnas.2502724122. Epub 2025 Jul 28.
6
Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.新型冠状病毒感染中的固有免疫、治疗靶点及单克隆抗体
PeerJ. 2025 Jun 20;13:e19462. doi: 10.7717/peerj.19462. eCollection 2025.
7
The age-dependent neuroglial interaction with peripheral immune cells in coronavirus-induced neuroinflammation with a special emphasis on COVID-19.冠状病毒诱导的神经炎症中年龄依赖性神经胶质细胞与外周免疫细胞的相互作用,特别关注新型冠状病毒肺炎。
Biogerontology. 2025 May 17;26(3):111. doi: 10.1007/s10522-025-10252-9.
8
MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis.介导持续性内质网应激/未折叠蛋白反应的MDA5蛋白促成皮肌炎中肺微血管内皮细胞的内皮-间充质转化。
Cell Commun Signal. 2025 Mar 23;23(1):149. doi: 10.1186/s12964-025-02159-2.
9
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy.胞质核酸感应作为危重症的驱动因素:机制与治疗进展
Signal Transduct Target Ther. 2025 Mar 19;10(1):90. doi: 10.1038/s41392-025-02174-2.
10
Anti-interferon armamentarium of human coronaviruses.人类冠状病毒的抗干扰素手段
Cell Mol Life Sci. 2025 Mar 13;82(1):116. doi: 10.1007/s00018-025-05605-z.
SARS-CoV-2 的 Orf6 劫持 Nup98 以阻断 STAT 核输入并拮抗干扰素信号通路。
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28344-28354. doi: 10.1073/pnas.2016650117. Epub 2020 Oct 23.
4
Physiologic RNA targets and refined sequence specificity of coronavirus EndoU.冠状病毒内切酶 EndoU 的生理 RNA 靶标和精细序列特异性。
RNA. 2020 Dec;26(12):1976-1999. doi: 10.1261/rna.076604.120. Epub 2020 Sep 28.
5
Evasion of Type I Interferon by SARS-CoV-2.SARS-CoV-2 对 I 型干扰素的逃避。
Cell Rep. 2020 Oct 6;33(1):108234. doi: 10.1016/j.celrep.2020.108234. Epub 2020 Sep 19.
6
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
7
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
8
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study.中国武汉42例新型冠状病毒肺炎死亡病例的流行病学及临床特征:一项回顾性研究
Biosaf Health. 2020 Sep;2(3):164-168. doi: 10.1016/j.bsheal.2020.07.007. Epub 2020 Jul 15.
9
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.SARS-CoV-2 小鼠模型揭示了 I 型干扰素信号通路的炎症作用。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20201241.
10
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.